Novel NPY2R agonist BI 1820237 provides synergistic anti-obesity efficacy when combined with the GCGR/GLP-1R dual agonist survodutide
Titel:
Novel NPY2R agonist BI 1820237 provides synergistic anti-obesity efficacy when combined with the GCGR/GLP-1R dual agonist survodutide
Auteur:
Augustin, Robert Oldenburger, Anouk Baader-Pagler, Tamara Zimmermann, Tina Borghardt, Jens Hecksher-Sørensen, Jacob Baljuls, Angela Reindl, Wolfgang Krawczyk, Bartlomiej Martel, Eric Brennauer, Albert Peters, Stefan Grube, Achim Rudkjaer, Lise Biehl Haebel, Peter